Fig. 3From: Clinical and event-based outcomes of patients with mucopolysaccharidosis VI receiving enzyme replacement therapy in Turkey: a case seriesNumber of events by age before and after initiation of ERT. Individual patient data. Events include recurrent infection episodes and upper airway/respiratory, mobility, cardiovascular, psychiatric, neurologic, ophthalmologic, hearing, pain, sleep, and abdominal events. Long-lasting events were only counted at the time the event started or restarted after a period of at least 0.5 years. Each data point represents the number of events over a 6-month period before or after initiation of enzyme replacement therapy (ERT)Back to article page